On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q4 2023 earnings per share (EPS) of $0.87, up 9.38% year over year. Total Bristol Myers Squibb Co earnings for the quarter were $1.76 billion. In the same quarter last year, Bristol Myers Squibb Co's earnings per share (EPS) was $0.96.
As of Q2 2024, Bristol Myers Squibb Co's earnings has grown 30.64% year over year. This is 30.69 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of -0.05%. Bristol Myers Squibb Co's earnings in the past year totalled $8.03 billion.
What was BMY's revenue last quarter?
On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q4 2023 revenue of $11.48 billion up 0.62% year over year. In the same quarter last year, Bristol Myers Squibb Co's revenue was $11.41 billion.
What was BMY's revenue growth in the past year?
As of Q2 2024, Bristol Myers Squibb Co's revenue has grown -2.5% year over year. This is 7.18 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 4.69%. Bristol Myers Squibb Co's revenue in the past year totalled $45.01 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.